Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Status:
RECRUITING
Trial end date:
2029-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the experimental treatment with poly-ADP ribose polymerase (PARP) inhibitor, ACE-86225106 is safe, tolerable and has anti-cancer activity in adult patients with advanced solid tumors.